| DC Field | Value | Language |
|---|
| dc.contributor.author | Pribylov, S. A. | - |
| dc.contributor.author | Leonidova, K. O. | - |
| dc.contributor.author | Pribylov, V. S. | - |
| dc.contributor.author | Gavrilyuk, E. V. | - |
| dc.contributor.author | Pribylova, N. N. | - |
| dc.date.accessioned | 2026-10-13T07:37:46Z | - |
| dc.date.available | 2026-10-13T07:37:46Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities / S.A. Pribylov, K.O. Leonidova, V.S. Pribylov [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №2.-P. 86-94. - DOI: 10.18413/rrpharmacology.12.1055. - Refer.: p. 94. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67124 | - |
| dc.description.abstract | Aim: To assess CRS marker dynamics and arterial stiffness in patients with ACS, AH, and chronic kidney disease (CKD) on standardized therapy, and to develop a treatment selection algorithm | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | cardiorenal syndrome | ru |
| dc.subject | acute coronary syndrome | ru |
| dc.subject | chronic kidney disease | ru |
| dc.subject | cystatin C | ru |
| dc.subject | microalbuminuria | ru |
| dc.subject | arterial stiffness | ru |
| dc.subject | amlodipine | ru |
| dc.subject | perindopril | ru |
| dc.subject | treatment algorithm | ru |
| dc.title | The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 2
|
